Stratos Ventures
VC Fund
Helsinki, Finland
Stratos Ventures is a European early stage venture capital firm with a focus on information and communication technology sectors. Stratos Ventures helps entrepreneurs in creating leading companies in the high growth areas of wireless communication, convergence and photonics. Stratos Ventures supports its high involvement investment model throughoffices in Helsinki, London and San Diego.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 11%
Last updated:
For AI agents: llms.txt
Industries Stratos Ventures invests in
SoftwareInformation ServicesInformation TechnologyWeb3Energy
Stages Stratos Ventures invests in
Series BSeries CSeedSeries ASeries D
Countries Stratos Ventures invests in
United StatesFinland
Round sizes
Series B $15M–$62MSeries C $6.2M–$12M
Round size
- Series B
- $15M–$62M
- Series C
- $6.2M–$12M
Investment Focus
Industry
- Software 2 (22%)
- Information Services 2 (22%)
- Information Technology 2 (22%)
- Web3 1 (11%)
- Energy 1 (11%)
Stage
- Series B 3 (33%)
- Series C 2 (22%)
- Seed 1 (11%)
- Series A 1 (11%)
- Series D 1 (11%)
Country
- United States 4 (44%)
- Finland 2 (22%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Burrata
|
Burrata is a computer software provider and developer that bridges Web2 to Web3. | $7.8M / Seed / Dec 09, 2021 | |
Universal Hydrogen
|
Universal Hydrogen is dedicated to making hydrogen aviation a near-term reality. The company is building a hydrogen ecosystem for aviation through strategic partnerships and new technologies for hydrogen distribution and propulsion. | $62M / Series B / Oct 14, 2021 | |
First Hop
|
First Hop offers mobile middleware products for the delivery and business management of wireless content services. It offers First Hop Wireless Broker, a modular service delivery platform that enables operators to create in-house and off-portal third-party service portfolios through provisioning workflows.The company is headquartered inHelsinki, Finland. | $7.9M / Oct 05, 2004 | |
CRF Health
|
CRF Health develops electronic clinical outcome assessment (eCOA) solutions for home and site-based phase I-IV clinical trials for various therapeutic areas and patient populations in the United States and internationally. Its eCOA solutions include Patient Reported Outcomes, Observer Reported Outcomes, and Clinician or Rater Reported Outcomes.CRF Health also provides TrialMax Touch, a handheld diary that patients at home or the caregiver use, TrialMax Slate that is designed for use by clinicians and caregivers on the study site, TrialMax Web, a web-based diary that is primarily designed for late phase trials, TrialStudio that enables the client to design and adapt eCOA questionnaires, TrialManager, a role-based online portal that provides instant visibility to patient-reported data; medical device integration solutions, and TrialMax Synapse that links TrialMax to eClinical systems. Moreover, CFR Health offers project management, collaborative design, data management, real time trial management, data collection networks, and patient-facing helpdesk support services. It provides its solutions for central nervous system, gastrointestinal, genitourinary, infectious disease, pain, respiratory, and vaccine studies for pharmaceutical and biotechnology companies. Timo Ahopelto, Jarkko Joki-Tokola and Jaakko Ollila founded CRF in 2000, which became CRF Health, with its headquarters in Plymouth Meeting in Pennsylvania. It has locations in the United States, the United Kingdom, Finland, and Romania. | $3.4M / Series D / Apr 06, 2004 | |
|
CRF Health
|
CRF Health develops electronic clinical outcome assessment (eCOA) solutions for home and site-based phase I-IV clinical trials for various therapeutic areas and patient populations in the United States and internationally. Its eCOA solutions include Patient Reported Outcomes, Observer Reported Outcomes, and Clinician or Rater Reported Outcomes.CRF Health also provides TrialMax Touch, a handheld diary that patients at home or the caregiver use, TrialMax Slate that is designed for use by clinicians and caregivers on the study site, TrialMax Web, a web-based diary that is primarily designed for late phase trials, TrialStudio that enables the client to design and adapt eCOA questionnaires, TrialManager, a role-based online portal that provides instant visibility to patient-reported data; medical device integration solutions, and TrialMax Synapse that links TrialMax to eClinical systems. Moreover, CFR Health offers project management, collaborative design, data management, real time trial management, data collection networks, and patient-facing helpdesk support services. It provides its solutions for central nervous system, gastrointestinal, genitourinary, infectious disease, pain, respiratory, and vaccine studies for pharmaceutical and biotechnology companies. Timo Ahopelto, Jarkko Joki-Tokola and Jaakko Ollila founded CRF in 2000, which became CRF Health, with its headquarters in Plymouth Meeting in Pennsylvania. It has locations in the United States, the United Kingdom, Finland, and Romania. | $6.2M / Series C / Dec 18, 2002 | |
Wicom Communications
|
(WiCom) Research Group is part of the Department of Information and Communication Technologies. | $12M / Series C / Sep 19, 2001 | |
|
CRF Health
|
CRF Health develops electronic clinical outcome assessment (eCOA) solutions for home and site-based phase I-IV clinical trials for various therapeutic areas and patient populations in the United States and internationally. Its eCOA solutions include Patient Reported Outcomes, Observer Reported Outcomes, and Clinician or Rater Reported Outcomes.CRF Health also provides TrialMax Touch, a handheld diary that patients at home or the caregiver use, TrialMax Slate that is designed for use by clinicians and caregivers on the study site, TrialMax Web, a web-based diary that is primarily designed for late phase trials, TrialStudio that enables the client to design and adapt eCOA questionnaires, TrialManager, a role-based online portal that provides instant visibility to patient-reported data; medical device integration solutions, and TrialMax Synapse that links TrialMax to eClinical systems. Moreover, CFR Health offers project management, collaborative design, data management, real time trial management, data collection networks, and patient-facing helpdesk support services. It provides its solutions for central nervous system, gastrointestinal, genitourinary, infectious disease, pain, respiratory, and vaccine studies for pharmaceutical and biotechnology companies. Timo Ahopelto, Jarkko Joki-Tokola and Jaakko Ollila founded CRF in 2000, which became CRF Health, with its headquarters in Plymouth Meeting in Pennsylvania. It has locations in the United States, the United Kingdom, Finland, and Romania. | Series B / Feb 15, 2001 | |
|
CRF Health
|
CRF Health develops electronic clinical outcome assessment (eCOA) solutions for home and site-based phase I-IV clinical trials for various therapeutic areas and patient populations in the United States and internationally. Its eCOA solutions include Patient Reported Outcomes, Observer Reported Outcomes, and Clinician or Rater Reported Outcomes.CRF Health also provides TrialMax Touch, a handheld diary that patients at home or the caregiver use, TrialMax Slate that is designed for use by clinicians and caregivers on the study site, TrialMax Web, a web-based diary that is primarily designed for late phase trials, TrialStudio that enables the client to design and adapt eCOA questionnaires, TrialManager, a role-based online portal that provides instant visibility to patient-reported data; medical device integration solutions, and TrialMax Synapse that links TrialMax to eClinical systems. Moreover, CFR Health offers project management, collaborative design, data management, real time trial management, data collection networks, and patient-facing helpdesk support services. It provides its solutions for central nervous system, gastrointestinal, genitourinary, infectious disease, pain, respiratory, and vaccine studies for pharmaceutical and biotechnology companies. Timo Ahopelto, Jarkko Joki-Tokola and Jaakko Ollila founded CRF in 2000, which became CRF Health, with its headquarters in Plymouth Meeting in Pennsylvania. It has locations in the United States, the United Kingdom, Finland, and Romania. | Series A / Oct 25, 2000 | |
Riot Entertainment
|
RIOT-E develops and distributes entertainment services and games for mobile devices in partnership with leading international entertainment and telecommunication companies. RIOT-E was established in February of 2000 and currently has offices in Helsinki, Singapore, and New York. RIOT-E currently employs 90 people, with an executive team drawn frombackgrounds in film, music, game production, and New Media. | $15M / Series B / Oct 13, 2000 |
Co-Investors
3i Group
4 deals together
Nordic Venture Partners (Sweden)
2 deals together
75 & Sunny
1 deal together
Accenture Technology Ventures
1 deal together
Airbus Ventures
1 deal together
Baller ventures
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
SaaS Investors
99,274 investors
Enterprise Investors
77,348 investors
Software Investors
50,021 investors
Energy Investors
25,111 investors
SaaS VC Funds
61,208 investors
Enterprise VC Funds
49,693 investors
Software VC Funds
31,919 investors
Energy VC Funds
20,690 investors
SaaS Investors in United States
47,640 investors
FAQ
What does Stratos Ventures invest in?
Stratos Ventures invests primarily in Software, Information Services and Information Technology startups, most often at Series B and Series C stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Stratos Ventures's check size?
Stratos Ventures typically joins rounds of $15M–$62M at Series B and $6.2M–$12M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Stratos Ventures participates in.
When did Stratos Ventures last invest?
The most recent investment recorded for Stratos Ventures closed in Dec 2021. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
